133 related articles for article (PubMed ID: 23147225)
1. Overexpression of TNF-α-converting enzyme in fibroblasts augments dermal fibrosis after inflammation.
Fukaya S; Matsui Y; Tomaru U; Kawakami A; Sogo S; Bohgaki T; Atsumi T; Koike T; Kasahara M; Ishizu A
Lab Invest; 2013 Jan; 93(1):72-80. PubMed ID: 23147225
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TNF-α converting enzyme promotes adipose tissue inflammation and fibrosis induced by high fat diet.
Matsui Y; Tomaru U; Miyoshi A; Ito T; Fukaya S; Miyoshi H; Atsumi T; Ishizu A
Exp Mol Pathol; 2014 Dec; 97(3):354-8. PubMed ID: 25236578
[TBL] [Abstract][Full Text] [Related]
3. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model.
Sato K; Takaishi M; Tokuoka S; Sano S
PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation.
Zhang Y; Jiang J; Black RA; Baumann G; Frank SJ
Endocrinology; 2000 Dec; 141(12):4342-8. PubMed ID: 11108241
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.
Cruz AC; Frank BT; Edwards ST; Dazin PF; Peschon JJ; Fang KC
J Biol Chem; 2004 Feb; 279(7):5612-20. PubMed ID: 14625290
[TBL] [Abstract][Full Text] [Related]
6. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17).
Budagian V; Bulanova E; Orinska Z; Ludwig A; Rose-John S; Saftig P; Borden EC; Bulfone-Paus S
J Biol Chem; 2004 Sep; 279(39):40368-75. PubMed ID: 15215246
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing.
Sakimoto T; Yamada A; Kanno H; Sawa M
Jpn J Ophthalmol; 2008; 52(5):393-398. PubMed ID: 18991041
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.
Endres K; Anders A; Kojro E; Gilbert S; Fahrenholz F; Postina R
Eur J Biochem; 2003 Jun; 270(11):2386-93. PubMed ID: 12755693
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells.
Shao MX; Ueki IF; Nadel JA
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11618-23. PubMed ID: 12972643
[TBL] [Abstract][Full Text] [Related]
11. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ
Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.
Sunnarborg SW; Hinkle CL; Stevenson M; Russell WE; Raska CS; Peschon JJ; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Lee DC
J Biol Chem; 2002 Apr; 277(15):12838-45. PubMed ID: 11823465
[TBL] [Abstract][Full Text] [Related]
13. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
Sharma M; Mohapatra J; Argade A; Deshpande SS; Shah GB; Chatterjee A; Jain MR
Immunopharmacol Immunotoxicol; 2014 Aug; 36(4):282-9. PubMed ID: 24946851
[TBL] [Abstract][Full Text] [Related]
15. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones.
Saito K; Horiuchi K; Kimura T; Mizuno S; Yoda M; Morioka H; Akiyama H; Threadgill D; Okada Y; Toyama Y; Sato K
PLoS One; 2013; 8(1):e54853. PubMed ID: 23349978
[TBL] [Abstract][Full Text] [Related]
16. Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation.
Wang Y; Sul HS
Mol Cell Biol; 2006 Jul; 26(14):5421-35. PubMed ID: 16809777
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).
Tsakadze NL; Sithu SD; Sen U; English WR; Murphy G; D'Souza SE
J Biol Chem; 2006 Feb; 281(6):3157-64. PubMed ID: 16332693
[TBL] [Abstract][Full Text] [Related]
18. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
Maretzky T; Zhou W; Huang XY; Blobel CP
Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
[TBL] [Abstract][Full Text] [Related]
19. Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivo.
Yoda M; Kimura T; Tohmonda T; Morioka H; Matsumoto M; Okada Y; Toyama Y; Horiuchi K
PLoS One; 2013; 8(1):e54412. PubMed ID: 23342154
[TBL] [Abstract][Full Text] [Related]
20. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
